A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin
Bernard M H Law1, Victoria A Spain, Veronica H L Leinster
1From the Department of Pharmacology, UCL School of Pharmacy, University College London 29-39 Brunswick Square, London WC1N 1AX, United Kingdom.
Abstract:
Mutations in LRRK2, encoding the multifunctional protein leucine-rich repeat kinase 2 (LRRK2), are a common cause of Parkinson disease. LRRK2 has been suggested to influence the cytoskeleton as LRRK2 mutants reduce neurite outgrowth and cause an accumulation of hyperphosphorylated Tau. This might cause alterations in the dynamic instability of microtubules suggested to contribute to the pathogenesis of Parkinson disease. Here, we describe a direct interaction between LRRK2 and β-tubulin. This interaction is conferred by the LRRK2 Roc domain and is disrupted by the familial R1441G mutation and artificial Roc domain mutations that mimic autophosphorylation. LRRK2 selectively interacts with three β-tubulin isoforms: TUBB, TUBB4, and TUBB6, one of which (TUBB4) is mutated in the movement disorder dystonia type 4 (DYT4). Binding specificity is determined by lysine 362 and alanine 364 of β-tubulin. Molecular modeling was used to map the interaction surface to the luminal face of microtubule protofibrils in close proximity to the lysine 40 acetylation site in α-tubulin. This location is predicted to be poorly accessible within mature stabilized microtubules, but exposed in dynamic microtubule populations. Consistent with this finding, endogenous LRRK2 displays a preferential localization to dynamic microtubules within growth cones, rather than adjacent axonal microtubule bundles. This interaction is functionally relevant to microtubule dynamics, as mouse embryonic fibroblasts derived from LRRK2 knock-out mice display increased microtubule acetylation. Taken together, our data shed light on the nature of the LRRK2-tubulin interaction, and indicate that alterations in microtubule stability caused by changes in LRRK2 might contribute to the pathogenesis of Parkinson disease.
Insights
Mutations in leucine-rich repeat kinase 2 (LRRK2) are linked to Parkinson disease. This study reveals LRRK2 directly interacts with β-tubulin, impacting microtubule dynamics and potentially contributing to Parkinson disease pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a leading genetic cause of Parkinson disease.
- LRRK2 is implicated in cytoskeletal regulation, with mutants affecting neurite outgrowth and Tau phosphorylation.
- Altered microtubule dynamics are suspected contributors to Parkinson disease pathogenesis.
Purpose of the Study:
- To investigate the direct interaction between LRRK2 and β-tubulin.
- To elucidate the role of this interaction in microtubule dynamics and Parkinson disease.
- To identify specific LRRK2 and β-tubulin interaction sites and their functional consequences.
Main Methods:
- Co-immunoprecipitation assays to detect LRRK2-β-tubulin interaction.
- Site-directed mutagenesis to identify key residues in LRRK2 and β-tubulin.
- Molecular modeling to map the interaction interface on microtubules.
- Analysis of microtubule dynamics in LRRK2 knockout mouse embryonic fibroblasts.
Main Results:
- A direct interaction between LRRK2 and β-tubulin was identified, mediated by the LRRK2 Roc domain.
- Specific β-tubulin isoforms (TUBB, TUBB4, TUBB6) were found to bind LRRK2, with binding specificity determined by β-tubulin residues Lys362 and Ala364.
- The interaction occurs on dynamic microtubules, particularly in growth cones, and is disrupted by Parkinson disease-associated mutations.
- LRRK2 knockout cells exhibit increased microtubule acetylation, indicating a role in regulating microtubule stability.
Conclusions:
- LRRK2 directly interacts with β-tubulin, influencing microtubule dynamics.
- Mutations in LRRK2 disrupt this interaction, potentially contributing to Parkinson disease.
- The LRRK2-tubulin interaction offers a new perspective on the molecular mechanisms underlying Parkinson disease pathogenesis.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Receptor Tyrosine Kinases
Destabilization of Microtubules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Microtubule Instability
Drugs that Stabilize Microtubules


